Office of the Secretary; Notice of Meeting, 37820-37821 [2018-16505]

Download as PDF 37820 Federal Register / Vol. 83, No. 149 / Thursday, August 2, 2018 / Notices DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Cancer Institute; Notice of Meeting daltland on DSKBBV9HB2PROD with NOTICES Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended, notice is hereby given of a meeting of the National Cancer Advisory Board. The meeting will be open to the public as indicated below, with attendance limited to space available. Individuals who plan to attend and need special assistance, such as sign language interpretation or other reasonable accommodations, should notify the Contact Person listed below in advance of the meeting. The open session will be videocast and can be accessed from the NIH Videocasting and Podcasting website (https:// videocast.nih.gov). The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Cancer Advisory Board. Date: August 14, 2018. Open: 1:00 p.m. to 2:45 p.m. Agenda: Director’s and Program reports and presentations; business of the Board. Closed: 2:55 p.m. to 4:00 p.m. Agenda: To review and evaluate grant applications. Place: National Cancer Institute—Shady Grove, 9609 Medical Center Drive, Room TE406, Rockville, MD 20850 (Virtual Meeting). Contact Person: Paulette S. Gray, Ph.D., Executive Secretary, Division of Extramural Activities, National Cancer Institute—Shady Grove, National Institutes of Health, 9609 Medical Center Drive, Room 7W444, Bethesda, MD 20892, 240–276–6340, grayp@ mail.nih.gov. This notice is being published less than 15 days prior to the meeting due to scheduling difficulties. Any interested person may file written comments with the committee by forwarding the statement to the Contact Person listed on this notice. The statement should include the name, address, telephone number and when applicable, the business or professional affiliation of the interested person. In the interest of security, NIH has instituted stringent procedures for entrance onto the NCI-Shady Grove campus. Visitors VerDate Sep<11>2014 17:06 Aug 01, 2018 Jkt 244001 will be asked to show one form of identification (for example, a governmentissued photo ID, driver’s license, or passport) and to state the purpose of their visit. Information is also available on the Institute’s/Center’s home page: https:// deainfo.nci.nih.gov/advisory/ncab/ncab.htm, where an agenda and any additional information for the meeting will be posted when available. (Catalogue of Federal Domestic Assistance Program Nos. 93.392, Cancer Construction; 93.393, Cancer Cause and Prevention Research; 93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer Centers Support; 93.398, Cancer Research Manpower; 93.399, Cancer Control, National Institutes of Health, HHS) Dated: July 26, 2018. Melanie J. Pantoja, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2018–16492 Filed 8–1–18; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health Center for Scientific Review; Notice of Closed Meeting Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: Center for Scientific Review Special Emphasis Panel; Member Conflict: Chemosensory Systems. Date: August 1, 2018. Time: 2:00 p.m. to 6:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892, (Telephone Conference Call). Contact Person: M. Catherine Bennett, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 5182, MSC 7846, Bethesda, MD 20892, 301–435– 1766, bennettc3@csr.nih.gov. This notice is being published less than 15 days prior to the meeting due to the timing PO 00000 Frm 00038 Fmt 4703 Sfmt 4703 limitations imposed by the review and funding cycle. (Catalogue of Federal Domestic Assistance Program Nos. 93.306, Comparative Medicine; 93.333, Clinical Research, 93.306, 93.333, 93.337, 93.393–93.396, 93.837–93.844, 93.846–93.878, 93.892, 93.893, National Institutes of Health, HHS) Dated: July 27, 2018. Sylvia L. Neal, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2018–16506 Filed 8–1–18; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health Office of the Secretary; Notice of Meeting Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended, notice is hereby given of a meeting of the Muscular Dystrophy Coordinating Committee (MDCC). The meeting will be open to the public and accessible by teleconference. Participation is limited to space available. Individuals who plan to participate and need special assistance, such as reasonable accommodations, should notify the Contact Person listed below in advance of the meeting. Name of Committee: Muscular Dystrophy Coordinating Committee. Type of meeting: Open Meeting. Date: September 17, 2018. Time: 2:00 p.m. to 5:00 p.m. *Eastern Time*—Approximate end time. Agenda: The purpose of this meeting is to bring together committee members, representing government agencies, patient advocacy groups, other voluntary health organizations, and patients and their families to update one another on progress relevant to the Action Plan for the Muscular Dystrophies and to coordinate activities and discuss gaps and opportunities leading to better understanding of the muscular dystrophies, advances in treatments, and improvements in patients’ and their families’ lives. Prior to the meeting, an agenda will be posted to the MDCC website: https://mdcc.nih.gov/. Registration: To register, please contact Emily Carifi: Emily.Carifi@nih.gov. WebEx/Phone Access: Join WebEx Meeting: https:// nih.webex.com/nih/j.php?MTID= m1c5fd34513186c7c87ebeeee5af47f05; Meeting number (access code): 628 888 923, Meeting password: fEN63PND Join by Phone: 1–650–479–3208 Call-in toll number (US/Canada) Global call-in numbers: https:// nih.webex.com/nih/globalcallin.php? serviceType=MC&ED=701170342&toll Free=0. E:\FR\FM\02AUN1.SGM 02AUN1 37821 Federal Register / Vol. 83, No. 149 / Thursday, August 2, 2018 / Notices Place: National Institutes of Health, Neuroscience Center, 6001 Executive Boulevard, Rockville, MD 20852, (Telephone Conference Call). Contact Person: Glen H. Nuckolls, Ph.D., Executive Secretary, Muscular Dystrophy Coordinating Committee, National Institute of Neurological Disorders and Stroke, NIH, 6001 Executive Boulevard, NSC 2203, Bethesda, MD 20892, (301) 496–5745, glen.nuckolls@nih.gov. Any member of the public interested in presenting oral comments to the committee may notify the Contact Person listed on this notice at least 10 days in advance of the meeting. Interested individuals and representatives of organizations may submit a letter of intent, a brief description of the organization represented, and a short description of the oral presentation. Only one representative of an organization may be allowed to present oral comments and if accepted by the committee, presentations may be limited to five minutes. Both printed and electronic copies are requested for the record. In addition, any interested person may file written comments with the committee by forwarding their statement to the Contact Person listed on this notice. The statement should include the name, address, telephone number and when applicable, the business or professional affiliation of the interested person. More information can be found on the Muscular Dystrophy Coordinating Committee home page: https://mdcc.nih.gov/. (Catalogue of Federal Domestic Assistance Program Nos. 93.853, Clinical Research Related to Neurological Disorders; 93.854, Biological Basis Research in the Neurosciences, National Institutes of Health, HHS) CBPL No. daltland on DSKBBV9HB2PROD with NOTICES [FR Doc. 2018–16505 Filed 8–1–18; 8:45 am] BILLING CODE 4140–01–P Notice is hereby given pursuant to 19 CFR 151.12 and 19 CFR 151.13, that Laboratory Service, Inc., 11731 Port Rd., Seabrook, TX 77586, has been approved to gauge petroleum and certain petroleum products and accredited to test petroleum and certain petroleum products for customs purposes, in accordance with the provisions of 19 CFR 151.12 and 19 CFR 151.13. Laboratory Service, Inc., is approved for the following gauging procedures for petroleum and certain petroleum products from the American Petroleum Institute (API): DEPARTMENT OF HOMELAND SECURITY U.S. Customs and Border Protection Accreditation and Approval of Laboratory Service, Inc., as a Commercial Gauger and Laboratory U.S. Customs and Border Protection, Department of Homeland Security. ACTION: Notice of accreditation and approval of Laboratory Service, Inc., as a commercial gauger and laboratory. AGENCY: Notice is hereby given, pursuant to CBP regulations, that Laboratory Service, Inc., has been approved to gauge petroleum and certain petroleum products and accredited to test petroleum and certain petroleum products for customs purposes for the next three years as of June 12, 2017. DATES: The accreditation and approval of Laboratory Service, Inc., as commercial gauger and laboratory became effective on June 12, 2017. The next triennial inspection date will be scheduled for June 2020. FOR FURTHER INFORMATION CONTACT: Melanie Glass, Laboratories and SUMMARY: API Chapters 3 .............. 7 .............. 8 .............. 12 ............ 17 ............ Title Tank gauging. Temperature determination. Sampling. Calculations. Maritime measurement. Laboratory Service, Inc. is accredited for the following laboratory analysis procedures and methods for petroleum and certain petroleum products set forth by the U.S. Customs and Border Protection Laboratory Methods (CBPL) and American Society for Testing and Materials (ASTM): Title D86 D4052 D1364 Standard Test Method for Distillation of Petroleum Products. Standard Test Method for Density and Relative Density of Liquids by Digital Density Meter. Standard Test Method for Water in Volatile Solvents (Karl Fischer Reagent Titration Method). Anyone wishing to employ this entity to conduct laboratory analyses and gauger services should request and receive written assurances from the entity that it is accredited or approved by the U.S. Customs and Border Protection to conduct the specific test or gauger service requested. Alternatively, inquiries regarding the specific test or gauger service this entity is accredited or approved to perform may be directed to the U.S. Customs and Border Protection by calling (202) 344–1060. The inquiry may also be sent to CBPGaugersLabs@cbp.dhs.gov. Please reference the website listed below for a complete listing of CBP approved gaugers and accredited laboratories. https://www.cbp.gov/about/labs- 17:06 Aug 01, 2018 Scientific Services Directorate, U.S. Customs and Border Protection, 1300 Pennsylvania Avenue NW, Suite 1500N, Washington, DC 20229, tel. 202–344– 2029. SUPPLEMENTARY INFORMATION: ASTM 27–08 .............. 27–48 .............. N/A .................. VerDate Sep<11>2014 Dated: July 27, 2018. Sylvia L. Neal, Program Analyst, Office of Federal Advisory Committee Policy. Jkt 244001 scientific/commercial-gaugers-andlaboratories. Dated: July 2, 2018. Dave Fluty, Executive Director, Laboratories and Scientific Services Directorate. [FR Doc. 2018–16516 Filed 8–1–18; 8:45 am] BILLING CODE 9111–14–P DEPARTMENT OF HOMELAND SECURITY [Docket No. DHS–2018–0035] First Responders Community of Practice Science and Technology Directorate, Department of Homeland Security. AGENCY: PO 00000 Frm 00039 Fmt 4703 Sfmt 4703 60-Day Notice of Information Collection; request for comment. (Extension of a Currently Approved Collection, 1640–0016). ACTION: The Department of Homeland Security (DHS), Science and Technology (S&T) First Responders Group (FRG) is proposing to extend currently approved OMB 1640–0016, an information collection, by inviting the public to comment on the collection: First Responders Community of Practice (FRCoP) User Registration Page (DHS Form 10059 (9/09)). The FRCoP web based tool collects profile information from first responders and select authorized non-first responder users to facilitate networking and formation of online communities. All users are SUMMARY: E:\FR\FM\02AUN1.SGM 02AUN1

Agencies

[Federal Register Volume 83, Number 149 (Thursday, August 2, 2018)]
[Notices]
[Pages 37820-37821]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2018-16505]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


Office of the Secretary; Notice of Meeting

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended, notice is hereby given of a meeting of the Muscular Dystrophy 
Coordinating Committee (MDCC).
    The meeting will be open to the public and accessible by 
teleconference. Participation is limited to space available. 
Individuals who plan to participate and need special assistance, such 
as reasonable accommodations, should notify the Contact Person listed 
below in advance of the meeting.

    Name of Committee: Muscular Dystrophy Coordinating Committee.
    Type of meeting: Open Meeting.
    Date: September 17, 2018.
    Time: 2:00 p.m. to 5:00 p.m. *Eastern Time*--Approximate end 
time.
    Agenda: The purpose of this meeting is to bring together 
committee members, representing government agencies, patient 
advocacy groups, other voluntary health organizations, and patients 
and their families to update one another on progress relevant to the 
Action Plan for the Muscular Dystrophies and to coordinate 
activities and discuss gaps and opportunities leading to better 
understanding of the muscular dystrophies, advances in treatments, 
and improvements in patients' and their families' lives. Prior to 
the meeting, an agenda will be posted to the MDCC website: https://mdcc.nih.gov/.
    Registration: To register, please contact Emily Carifi: 
[email protected].
    WebEx/Phone Access:

    Join WebEx Meeting: https://nih.webex.com/nih/j.php?MTID=m1c5fd34513186c7c87ebeeee5af47f05;
    Meeting number (access code): 628 888 923, Meeting password: 
fEN63PND
Join by Phone: 1-650-479-3208 Call-in toll number (US/Canada)
Global call-in numbers: https://nih.webex.com/nih/globalcallin.php?serviceType=MC&ED=701170342&tollFree=0.


[[Page 37821]]


    Place: National Institutes of Health, Neuroscience Center, 6001 
Executive Boulevard, Rockville, MD 20852, (Telephone Conference 
Call).
    Contact Person: Glen H. Nuckolls, Ph.D., Executive Secretary, 
Muscular Dystrophy Coordinating Committee, National Institute of 
Neurological Disorders and Stroke, NIH, 6001 Executive Boulevard, 
NSC 2203, Bethesda, MD 20892, (301) 496-5745, [email protected].

    Any member of the public interested in presenting oral comments 
to the committee may notify the Contact Person listed on this notice 
at least 10 days in advance of the meeting. Interested individuals 
and representatives of organizations may submit a letter of intent, 
a brief description of the organization represented, and a short 
description of the oral presentation. Only one representative of an 
organization may be allowed to present oral comments and if accepted 
by the committee, presentations may be limited to five minutes. Both 
printed and electronic copies are requested for the record. In 
addition, any interested person may file written comments with the 
committee by forwarding their statement to the Contact Person listed 
on this notice. The statement should include the name, address, 
telephone number and when applicable, the business or professional 
affiliation of the interested person.
    More information can be found on the Muscular Dystrophy 
Coordinating Committee home page: https://mdcc.nih.gov/.

(Catalogue of Federal Domestic Assistance Program Nos. 93.853, 
Clinical Research Related to Neurological Disorders; 93.854, 
Biological Basis Research in the Neurosciences, National Institutes 
of Health, HHS)


    Dated: July 27, 2018.
Sylvia L. Neal,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2018-16505 Filed 8-1-18; 8:45 am]
 BILLING CODE 4140-01-P

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.